705 related articles for article (PubMed ID: 18692506)
1. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
Bryson S; Julien JP; Isenman DE; Kunert R; Katinger H; Pai EF
J Mol Biol; 2008 Oct; 382(4):910-9. PubMed ID: 18692506
[TBL] [Abstract][Full Text] [Related]
2. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
Julien JP; Bryson S; Nieva JL; Pai EF
J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope.
Menendez A; Chow KC; Pan OC; Scott JK
J Mol Biol; 2004 Apr; 338(2):311-27. PubMed ID: 15066434
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis and in vivo administration of an anti-idiotypic antibody against mAb 2F5.
Gach JS; Quendler H; Strobach S; Katinger H; Kunert R
Mol Immunol; 2008 Feb; 45(4):1027-34. PubMed ID: 17804071
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
McGaughey GB; Citron M; Danzeisen RC; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller M; Shiver J; Bogusky MJ
Biochemistry; 2003 Mar; 42(11):3214-23. PubMed ID: 12641452
[TBL] [Abstract][Full Text] [Related]
6. Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5.
Kunert RE; Weik R; Ferko B; Stiegler G; Katinger H
AIDS; 2002 Mar; 16(4):667-8. PubMed ID: 11873012
[TBL] [Abstract][Full Text] [Related]
7. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41.
Cardoso RM; Zwick MB; Stanfield RL; Kunert R; Binley JM; Katinger H; Burton DR; Wilson IA
Immunity; 2005 Feb; 22(2):163-73. PubMed ID: 15723805
[TBL] [Abstract][Full Text] [Related]
8. Partial humanization and characterization of an anti-idiotypic antibody against monoclonal antibody 2F5, a potential HIV vaccine?
Gach JS; Quendler H; Weik R; Katinger H; Kunert R
AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1405-15. PubMed ID: 18184084
[TBL] [Abstract][Full Text] [Related]
9. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698
[TBL] [Abstract][Full Text] [Related]
10. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.
Luftig MA; Mattu M; Di Giovine P; Geleziunas R; Hrin R; Barbato G; Bianchi E; Miller MD; Pessi A; Carfí A
Nat Struct Mol Biol; 2006 Aug; 13(8):740-7. PubMed ID: 16862157
[TBL] [Abstract][Full Text] [Related]
12. Humanization strategies for an anti-idiotypic antibody mimicking HIV-1 gp41.
Mader A; Kunert R
Protein Eng Des Sel; 2010 Dec; 23(12):947-54. PubMed ID: 21037278
[TBL] [Abstract][Full Text] [Related]
13. Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response.
Ho J; Uger RA; Zwick MB; Luscher MA; Barber BH; MacDonald KS
Vaccine; 2005 Feb; 23(13):1559-73. PubMed ID: 15694508
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region.
Nicely NI; Dennison SM; Spicer L; Scearce RM; Kelsoe G; Ueda Y; Chen H; Liao HX; Alam SM; Haynes BF
Nat Struct Mol Biol; 2010 Dec; 17(12):1492-4. PubMed ID: 21076400
[TBL] [Abstract][Full Text] [Related]
15. Constrained peptide models from phage display libraries highlighting the cognate epitope-specific potential of the anti-HIV-1 mAb 2F5.
Palacios-Rodríguez Y; Gazarian T; Huerta L; Gazarian K
Immunol Lett; 2011 Apr; 136(1):80-9. PubMed ID: 21237206
[TBL] [Abstract][Full Text] [Related]
16. Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodies.
Lopalco L; Longhi R; Ciccomascolo F; De Rossi A; Pelagi M; Andronico F; Moore JP; Schulz T; Beretta A; Siccardi AG
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):33-9. PubMed ID: 7678970
[TBL] [Abstract][Full Text] [Related]
17. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.
Zwick MB; Komori HK; Stanfield RL; Church S; Wang M; Parren PW; Kunert R; Katinger H; Wilson IA; Burton DR
J Virol; 2004 Mar; 78(6):3155-61. PubMed ID: 14990736
[TBL] [Abstract][Full Text] [Related]
18. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
Tumanova OIu; Kuvshinov VN; Azaev MSh; Masharskiĭ AE; Klimov NA; Kozlov AP; Il'ichev AA; Sandakhchiev LS
Mol Biol (Mosk); 2001; 35(1):146-51. PubMed ID: 11234374
[TBL] [Abstract][Full Text] [Related]
19. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.
Calarese DA; Scanlan CN; Zwick MB; Deechongkit S; Mimura Y; Kunert R; Zhu P; Wormald MR; Stanfield RL; Roux KH; Kelly JW; Rudd PM; Dwek RA; Katinger H; Burton DR; Wilson IA
Science; 2003 Jun; 300(5628):2065-71. PubMed ID: 12829775
[TBL] [Abstract][Full Text] [Related]
20. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
Nelson JD; Brunel FM; Jensen R; Crooks ET; Cardoso RM; Wang M; Hessell A; Wilson IA; Binley JM; Dawson PE; Burton DR; Zwick MB
J Virol; 2007 Apr; 81(8):4033-43. PubMed ID: 17287272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
